VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Withholding Ramipril
Preclinical
Small molecule
T
Tanta University
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
ACE Inhibitors
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
ACE Inhibitors
Preclinical
Completed
Clinical
Trials by Indication
[1]
ACE Inhibitors
1 trial
Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography
Completed
·
T
Tanta University
·
N/A
·
NCT07184918
·
44 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Withholding Ramipril. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Withholding Ramipril compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Withholding Ramipril. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Tanta University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
T
Tanta University
Related News